Lyra Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYRA and other ETFs, options, and stocks.About LYRA
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases.
CEOMaria Palasis
CEOMaria Palasis
Employees30
Employees30
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2005
Founded2005
Employees30
Employees30
LYRA Key Statistics
Market cap6.24M
Market cap6.24M
Price-Earnings ratio-0.08
Price-Earnings ratio-0.08
Dividend yield—
Dividend yield—
Average volume12.85M
Average volume12.85M
High today$0.1007
High today$0.1007
Low today$0.0906
Low today$0.0906
Open price$0.092
Open price$0.092
Volume1.04M
Volume1.04M
52 Week high$0.398
52 Week high$0.398
52 Week low$0.082
52 Week low$0.082
People also own
Based on the portfolios of people who own LYRA. This list is generated using Robinhood data, and it’s not a recommendation.